Novavax(NVAX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Press Release Novavax Reports First Quarter 2024 Financial Results and Operational Highlights GAITHERSBURG, Md., May 10, 2024 – Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced its financial results and operational highlights for the first quarter ended March 31, 2024. Earlier today, Novavax and Sanofi (NASDAQ: SNY) announced that they have entered into a co-exclusive licensing agreement. The terms of the agreement incl ...